1. Home
  2. DUOT vs IMUX Comparison

DUOT vs IMUX Comparison

Compare DUOT & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DUOT
  • IMUX
  • Stock Information
  • Founded
  • DUOT 1990
  • IMUX 2016
  • Country
  • DUOT United States
  • IMUX United States
  • Employees
  • DUOT N/A
  • IMUX N/A
  • Industry
  • DUOT Computer Software: Prepackaged Software
  • IMUX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DUOT Technology
  • IMUX Health Care
  • Exchange
  • DUOT Nasdaq
  • IMUX Nasdaq
  • Market Cap
  • DUOT 66.3M
  • IMUX 67.8M
  • IPO Year
  • DUOT N/A
  • IMUX N/A
  • Fundamental
  • Price
  • DUOT $7.23
  • IMUX $0.83
  • Analyst Decision
  • DUOT Strong Buy
  • IMUX Strong Buy
  • Analyst Count
  • DUOT 2
  • IMUX 6
  • Target Price
  • DUOT $12.50
  • IMUX $11.60
  • AVG Volume (30 Days)
  • DUOT 145.9K
  • IMUX 1.6M
  • Earning Date
  • DUOT 08-12-2025
  • IMUX 08-07-2025
  • Dividend Yield
  • DUOT N/A
  • IMUX N/A
  • EPS Growth
  • DUOT N/A
  • IMUX N/A
  • EPS
  • DUOT N/A
  • IMUX N/A
  • Revenue
  • DUOT $11,162,390.00
  • IMUX N/A
  • Revenue This Year
  • DUOT $294.36
  • IMUX N/A
  • Revenue Next Year
  • DUOT $43.87
  • IMUX N/A
  • P/E Ratio
  • DUOT N/A
  • IMUX N/A
  • Revenue Growth
  • DUOT 89.27
  • IMUX N/A
  • 52 Week Low
  • DUOT $2.03
  • IMUX $0.56
  • 52 Week High
  • DUOT $9.27
  • IMUX $2.11
  • Technical
  • Relative Strength Index (RSI)
  • DUOT 45.98
  • IMUX 55.91
  • Support Level
  • DUOT $7.11
  • IMUX $0.68
  • Resistance Level
  • DUOT $8.20
  • IMUX $0.83
  • Average True Range (ATR)
  • DUOT 0.49
  • IMUX 0.05
  • MACD
  • DUOT -0.04
  • IMUX 0.02
  • Stochastic Oscillator
  • DUOT 18.99
  • IMUX 88.50

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: